Ann Sullivan

Chelsea & Westminister Hospital, United Kingdom

Dr Ann Sullivan trained in Australia and London, gaining an MD in HIV Immunology. She is now a Consultant at Chelsea and Westminster Hospital. Her specific interests include expanding HIV testing, MSM sexual health and utilising technology to improve patient care and experience. As Vice Chair of the BHIVA Audit and Standards Subcommittee, she led the 2014 National HIV Partner Notification audit. Dr Sullivan was elected as BHIVA Honorary Secretary in 2016 for a 2-year term.

Ben Collins

ReShape, IHP, UK

Ben Collins is a community organiser; director, ReShape/IHP; board member, EATG; chair, European Testing Week working group; co-founder, European Chemsex Forum; advisory committee, EACS’ WAVE; collaborator, Science Health Education (SHE) Centre; HIV+, 1982; undetectable; 1998.

Brian Gazzard

Professor of Medicine, Imperial College School of Medicine HIV Research Director, Chelsea & Westminster Hospital, UK

Brian Gazzard is the founding chairman of the British HIV Association (BHIVA) and sits on the Editorial Board of the BHIVA/EACS journal HIV Medicine.

Cary James

Chief Executive – World Hepatitis Alliance United Kingdom

Cary James is chief executive of the World Hepatitis Alliance – a network of community-based organisation in over 100 countries. He is the former Head of Health Improvement Programmes at the Terrence Higgins Trust and head of the HIV Prevention England (HPE) programme in the UK. Cary was the European Testing Week Working Group Co-chair from 2016-2017. He holds a masters degree in Health and Social Marketing.

Daniel Simões

Coalition PLUS/GAT (Portugal)

Daniel is a Psychologist working in the third sector since 2004, and a Global Public Health PhD student. Currently Monitoring and Evaluation manager at Coalition PLUS, based in Lisbon. Daniel has been working with GAT (Portugal) since 2011 in both project management and policy/advocacy. He is an EATG member, co-chair of EuroTEST, and one of the representatives from Portugal in the EU CSF on HIV, AIDS, viral hepatitis and Tuberculosis.

Daniela Rojas Castro

Coalition PLUS, France

Ferenc Bagyinszky

AIDS Action Europe, Germany

Francesco Negro

European Association for the Study of the Liver, Switzerland

Igor Karpov

Professor, Department of Infectious Disease Belarus State Medical University

Irith De Baetselier

Antwerp Institute of Tropical Medicine, Belgium

Jack Lambert

UCD, Ireland (INTEGRATE WP leader)

Professor Jack Lambert is a Consultant in Infectious diseases and genitourinary medicine at the Mater hospital and Rotunda Maternity hospital in Dublin since 2005, he also has an adjunct academic teaching appointment at the UCD School of Medicine. Professor Lambert has over 25 years experience, in Infectious Diseases covering HIV, Hepatitis C, and other disease areas. He trained in the USA, UK, and worked for 6 years in Baltimore at the Johns Hopkins Institutes and the University of Maryland Institute of Human Virology, where he developed his skills in vaccinology, HIV, and Lyme and Co Infections. He has consultant specialty certifications in adult and pediatric infectious diseases, general medicine and pediatrics, and in sexual health (genitourinary medicine). He was director of the National Isolation Unit at the Mater Hospital from 2010-2018. He has also been involved in the Sexual Health Strategy group in Ireland and teaching GP’s throughout the country on the subject of STD’S. During his time in Ireland, he has presented widely in the field of HIV, hepatitis, tropical medicine, and lyme and co infections.

Jeffrey V. Lazarus

Professor of International Health Systems, University of Copenhagen Denmark

Prof Lazarus is an expert on infectious disease policy and health systems. He is Vice-Chairman of the board of the EASL International Liver Foundation, co-chair of the HIV Outcomes Beyond Viral Suppression coalition and a steering committee member of the European Commission’s Joint Actions on infectious diseases.

Jens D. Lundgren

MD, Professor of Viral Diseases, University of Copenhagen; Director, CHIP, Copenhagen, Denmark.

Professor Lundgren established CHIP, Centre for Health & Infectious Disease Research in 1994. Since, he has been actively involved in international research in the field of infectious diseases, viral infections and HIV in particular. Further, he co-chaired the HIV in Europe initiative from its conception in 2007 until 2014.

Johanna Brännström

Department of Infectious Diseases, South Hospital & Institute of Medicine, Karolinska Institute, Stockholm, Sweden

Johanna Brännström is a MD, PhD and Senior Consultant, trained at Karolinska Institute (KI), Stockholm. She has >20 years of experience in Infectious Diseases, with a sub-specialisation in HIV. Her main focuses in research are the Continuum of Care (CoC), the undiagnosed population and late diagnosis of HIV-1 infection, which was also the focus of her thesis; Assessment of patients with late diagnosis and missed opportunities in the Swedish HIV-1 epidemic, 2016. Currently she is working as a Senior Consultant at the Clinic of Infectious diseases/Venhälsan at Södersjukhuset, Stockholm, combining clinical work with translational research at KI, Karolinska University Hospital. She is the PI for the Swedish “TIME” study, which aims at developing methodology for assessment of the undiagnosed HIV population and a representative in EuroSIDA (Respond). She is a Steering Committee member of InfCareHIV, the national Swedish HIV quality register and research database. She also provides expert advice to the Infectious Diseases Control Unit in Stockholm and to the Public Health agency of Sweden.

Jordi Casabona

Scientific Director, Center for HIV/STI Epidemiological Studies of Catalonia (CEEISCAT)

Jordi Casabona is a medical epidemiologist working on the HIV/STI field since 1989. He is the Scientific Director of the Center for Epidemiological Studies on HIV/STI of Catalonia (CEEISCAT) (www.ceeiscat.cat), President of the Fundació Sida i Societat and Associated Professor of Epidemiology and Preventive Medicine at the Autonomous University of Barcelona (UAB). He has been acting as a expert consultant for a number of international agencies in Latin America, Europe and Central Asia, was the co-chair of the XIV International AIDS Conference (Barcelona 2002), has implemented different interventions in Guatemala and has been leading several European Union funded projects, during last years focusing in the monitoring and evaluation of community based testing.

Jürgen Rockstroh

MD, Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn, Germany

An active member of the HIV/AIDS treatment community, Dr Rockstroh was the Chairman of the German Clinical AIDS Working Group (KAAD) from 1998 to 2007. From 2007 to 2011, he was elected as the president of the German AIDS Society. He is currently President of the European AIDS Clinical Society (EACS) Governing Board.

Kira Grazava

TB Coalition Europe, Ukraine

Lella Cosmaro

Fondazione LILA Milan, Italy (INTEGRATE WP leader)

Lella Cosmaro has been working in the HIV field since 1993 in an Italian NGO, LILA - the Italian League for Fighting AIDS - one of the leading national organizations. Over the years, LILA has become more and more involved in European policies and networks: Lella is the Italian member of the EU HIV/AIDS, Hepatitis and Tuberculosis Civil Society Forum, which she co-chaired for the period 2012-2015. She has been a Steering Committee member of AIDS Action Europe from 2011 thru 2016, is one of the External Advisory Board Members of the EATG, has been the civil society expert in a number of WHO missions in the European Region and is involved in some of the ECDC advisory groups. LILA has been and still is a partner of many European projects and Joint Actions and is deeply involved in Italian projects, advocacy and policy issues.

Liudmyla Maistat

Policy and Advocacy Manager, The Medicines Patent Pool, Geneva, Switzerland

Liudmyla possesses more than 15 years of policy and advocacy experience in HIV/AIDS, viral hepatitis and access to medicines. She used to work as Senior Program Advisor with the Alliance for Public Health (International HIV/AIDS Alliance in Ukraine) where she led policy and policy activities to support the scale-up of hepatitis C diagnostics and treatment in Ukraine, EECA and other countries where Alliance operates. Liudmyla is a member of the World Health Organization (WHO) Strategy and Technical Advisory Group on viral hepatitis and the WHO guidelines’ development and peer-review groups as well as a member of the Lancet Commission on Accelerating the Elimination of Viral hepatitis. She used to chair the Hepatitis C Group for Unitaid’s NGO delegation, worked closely with various civil society groups and other stakeholders working to expand access to treatments, and continues to serve as a member of organizing and scientific committees for international conferences and meetings on HIV, viral hepatitis and access to medicines. Liudmyla was recognized by the Economist as one of the leading voices for advocacy to increase access to affordable diagnostics and treatment of viral hepatitis. Liudmyla now works with the Medicines Patent Pool as Policy and Advocacy Manager to scale up access to affordable and quality assured HIV, viral hepatitis and TB medicines in low- and middle income countries.

Magnus Unemo

WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Örebro University Hospital, Sweden

Mark Vermeulen

Aidsfonds – Soa Aids Nederland, Netherlands

Mojca Matičič

University Medical Centre Ljubljana

Mojca Matičič has been the Head of the Viral Hepatitis Unit at the Clinic for Infectious Diseases and Febrile Illnesses, and Head of the Outpatient STI Service at the University Medical Centre Ljubljana. She leads the multidisciplinary National Viral Hepatitis Expert Group of Slovenia and is an active member of the HIV/AIDS Committee at the Slovene Ministry of Health. She is a member of the European Association for the Study of the Liver (EASL), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and advisor at WHO HIV/STD/Viral Hepatitis sector. She is a senior clinical editor of the international medical journal Hepatology, Medicine and Policy (HMAP).

Nikos Dedes

Past Chair of the Board of Directors European AIDS Treatment Group (EATG), Greece

Nikos Dedes is the founder and chair of ‘Positive Voice’, the Greek Association of People Living with HIV and the founder and vice-chair of ‘Prometheus’, the Hellenic Liver Patient Association. He is a past member of the Management Board of the European Medicines Agency (EMA). Nikos participates on the Steering Committees of NEAT id (European HIV Clinical Trials Foundation) and the “HIV Outcomes – Beyond Viral Suppression” initiatives. He is a member of the HIV Treatment Guidelines Panel of the European AIDS Clinical Society (EACS) and a member of the Coordinating Team of the HIV/AIDS, Hepatitis & TB Civil Society Forum, an advisory group to DG Sante of the European Commission. He is also a member of the National Clinical Trials Ethics Committee and a member of the Board of Directors of the European Forum for Good Clinical Practice (EFGCP).

Nino Tsereteli

Executive Director of "Tanadgoma" Georgia

Nino Tsereteli has been working in the field of HIV/AID for more than 12 years. In 2000, together with the group of young professionals, she founded a Non-Governmental Organization “Center for Information and Counseling on Reproductive Health – Tanadgoma”, aiming at prevention of HIV and STIs and promoting reproductive health issues among Georgian population. In 2007 Ms. Tsereteli was appointed as Executive Director of “Tanadgoma”.

Rajul Patel

Department of Genitourinary Medicine, Southampton University Hospitals & International Union against Sexually Transmitted Infections (IUSTI), United Kingdom

Tom Platteau

HIV/STI clinic of the Institute of Tropical Medicine in Antwerp

Tom Platteau is mental health scientist and sexologist. He works at the HIV/STI clinic of the Institute of Tropical Medicine in Antwerp, Belgium. Since 2007, he coordinates projects on the development and implementation of novel HIV/STI testing using outreach and online strategies.

Valerie Delpech

Epidemiologist, Public Health England United Kingdom

Valerie Delpech oversees the national surveillance of HIV based at Public Health England, London, United Kingdom. She provides expert advise on a number of national and international committees and expert groups in relation to HIV surveillance, prevention and policy development and led on the production of the European Centre for Disease Control (ECDC) evidence and guidance to increase HIV testing across Europe.

Yazdan Yazdanpanah

NSERM, France

Prof Yazdan Yazdanpanah, Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology, Head of an Inserm team on decision analysis in Infectious Diseases, and Professor of Medicine at Paris Diderot University, France ; Head of Infectious Disease department at Bichat Claude Bernard Hospital. Yazdan Yazdanpanah is currently the head of an Inserm team on decision analysis in Infectious Diseases, the Head of Infectious Disease department at Bichat Claude Bernard Hospital, and Professor of Medicine at Paris Diderot University, France. Yazdan Yazdanpanah became an MD from the Lille School of Medicine, France in 1996. He qualified from the same institution first as a hepato- gastro-enterologist in 1996 and next an infectious disease specialist in 2002. He obtained a Master of Science degree in epidemiology from the Harvard School of Public Health, Boston, US in 2000, and a Ph.D degree in public health from the Bordeaux School of Public Health in 2002. In 2006, he became Professor of Infectious Disease. His research interests include the clinical epidemiology of HIV and viral hepatitis, and the pharmaco-economics of antimicrobial agents. He is one of the coordinators of Inserm “REACTing », a network under the umbrella of Aviesan (REsearch and ACTion targeting emerging infectious disease) the goal of which is to optimize and coordinate the existing research capacities during emerging and re-emerging infection threats. He was recently appointed Director of Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology. Professor Yazdanpanah has published extensively in peer-reviewed journals and makes frequent presentations at numerous national and international meetings.